9FWJ
Ensemble model of ligand-free SARS-CoV-2 NSP10-NSP14 (ExoN) and in complex with partially bound VT00079
Experimental procedure
| Experimental method | SINGLE WAVELENGTH |
| Source type | SYNCHROTRON |
| Source details | MAX IV BEAMLINE BioMAX |
| Synchrotron site | MAX IV |
| Beamline | BioMAX |
| Temperature [K] | 100 |
| Detector technology | PIXEL |
| Collection date | 2022-06-03 |
| Detector | DECTRIS EIGER X 16M |
| Wavelength(s) | 0.97625 |
| Spacegroup name | P 21 21 21 |
| Unit cell lengths | 61.193, 70.522, 108.654 |
| Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
| Resolution | 59.150 - 2.424 |
| R-factor | 0.2149 |
| Rwork | 0.213 |
| R-free | 0.25420 |
| Structure solution method | FOURIER SYNTHESIS |
| RMSD bond length | 0.007 |
| RMSD bond angle | 0.930 |
| Data reduction software | XDS |
| Data scaling software | Aimless |
| Phasing software | DIMPLE |
| Refinement software | BUSTER (2.10.4) |
Data quality characteristics
| Overall | Inner shell | Outer shell | |
| Low resolution limit [Å] | 59.154 | 59.154 | 2.466 |
| High resolution limit [Å] | 2.424 | 6.577 | 2.424 |
| Rmerge | 0.143 | 0.052 | 1.316 |
| Rmeas | 0.148 | 0.055 | 1.366 |
| Rpim | 0.040 | 0.015 | 0.364 |
| Total number of observations | 246416 | 12387 | 12413 |
| Number of reflections | 18402 | 1016 | 898 |
| <I/σ(I)> | 13.55 | 35.49 | 2.34 |
| Completeness [%] | 99.7 | 99.6 | 99.6 |
| Redundancy | 13.39 | 12.19 | 13.82 |
| CC(1/2) | 0.997 | 0.998 | 0.798 |
| Anomalous redundancy | 7.2 | 7.3 | 7.3 |
| CC(ano) | -0.062 | 0.214 | 0.032 |
| |DANO|/σ(DANO) | 0.8 | 1.2 | 0.8 |
Crystallization Conditions
| crystal ID | method | pH | temperature | details |
| 1 | VAPOR DIFFUSION, SITTING DROP | 293 | Morpheus buffer 2 (pH: 7.5): 0.10M - Morpheus Ethylene glycols: 27.50%w/v Morpheus Amino acids: 0.20M |






